Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Open-label Extension to Protocol 1042-0600

ClinicalTrials.gov ID: NCT00512317

Public ClinicalTrials.gov record NCT00512317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To allow open-label extension to patients who have completed Protocol 1042-0600.

Study identification

NCT ID
NCT00512317
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Marinus Pharmaceuticals
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2007 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Sep 2013 (Actual)
Last update posted
Jan 17, 2023

2007 – 2013

United States locations

U.S. sites
25
U.S. states
21
U.S. cities
25
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294-0021 —
Barrow Neurological Institute Phoenix Arizona 85013 —
Arkansas Epilepsy Program Little Rock Arkansas 72205 —
University of Southern California Adult Comprehensive Epilepsy Center Los Angeles California 90033 —
University of California-Davis Sacramento California 95817 —
Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital Aurora Colorado 80010-0045 —
Yale University School of Medicine New Haven Connecticut 06520 —
University of Florida McKnight Brain Institute Gainesville Florida 32610-0236 —
Intercoastal Neurology Sarasota Florida 34232 —
Emory HealthCare Atlanta Georgia 30322 —
Southern Illinois University Medical Center Springfield Illinois 62702 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Kentucky, Dept. of Neurology Lexington Kentucky 40536 —
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817 —
2799 West Grand blvd. CFP 071 Detroit Michigan 48202 —
Minnesota Epilepsy Group, PA Saint Paul Minnesota 55102-2383 —
Comprehensive Epilepsy Care Center for Children and Adults Chesterfield Missouri 63017 —
Neurosciences Institute at Albany Medical Center Albany New York 12208 —
SUNY Upstate Medical University Syracuse New York 13210 —
Ohio State University Medical Center Columbus Ohio 43210 —
Riddle Health Care Center for Neuroscience Media Pennsylvania 19063 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Neurological Clinic of Texas, P.A. Dallas Texas 75230 —
Virginia Commonwealth University Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00512317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00512317 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →